While therapeutic monoclonal antibodies (mAbs) have been on the market for over 25 years, it wasn’t until recently that the production of these essential biologics began to move away from traditional ...
To get industry experts talking together about continuous processing of monoclonal antibodies (mAbs), the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) in Newark, DE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results